Moreover, GnT-V−/− tumour cells display reduced galectin-3 binding to complex N-glycans on high-n receptors and increased high-n receptors' mobility on cell membrane and, thus, movement into both caveoli and coated-pits, but limited low-n receptor internalization and maintain downstream signalling sensitivity 53,54. The gene discussed is MGAT5; the disease is neoplasm.